The pathophysiology and pharmacological treatment of Huntington disease. (Record no. 21878010)

MARC details
000 -LEADER
fixed length control field 01304 a2200337 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516100002.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201406s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1875-8584
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3233/BEN-2012-120267
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pidgeon, Connie
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140606
245 00 - TITLE STATEMENT
Title The pathophysiology and pharmacological treatment of Huntington disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Behavioural neurology
Date of publication, distribution, etc. 2013
300 ## - PHYSICAL DESCRIPTION
Extent 245-53 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review; Systematic Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antidepressive Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Basal Ganglia
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cannabinoids
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cholinesterase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Excitatory Amino Acid Antagonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element GABA Agonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Huntington Disease
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroprotective Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tetrabenazine
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rickards, Hugh
773 0# - HOST ITEM ENTRY
Title Behavioural neurology
Related parts vol. 26
-- no. 4
-- p. 245-53
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3233/BEN-2012-120267">https://doi.org/10.3233/BEN-2012-120267</a>
Public note Available from publisher's website

No items available.